Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 29-Dec-23 5:40 PM View:  | Applied Molecular Transport... (AMTI) | 27-Dec-23 | Disposition (other) | 8,337,520 | -- | -- | (100%) 8.34M to 0 | |
| 16-Dec-22 5:38 PM View: | Lucira Health, Inc. (LHDX) | 14-Dec-22 | Acquisition (other) | 982,417 | -- | -- | 3% 29.88M to 30.86M | |
| 16-Dec-22 5:38 PM View: | Lucira Health, Inc. (LHDX) | 14-Dec-22 | Disposition (other) | 13,124,300 | -- | -- | (43%) 30.86M to 17.74M | |
| 16-May-22 5:49 PM View: | Applied Molecular Transport... (AMTI) | 13-May-22 | Purchase | 29,763 | $4.17 | $124,124.00 | < 1% 8.31M to 8.34M | |
| 16-May-22 5:49 PM View: | Applied Molecular Transport... (AMTI) | 12-May-22 | Private Purchase | 32,380 | $3.88 | $125,634.00 | < 1% 8.28M to 8.31M | |
| 18-Nov-21 3:41 PM View: | Applied Molecular Transport... (AMTI) | 17-Nov-21 | Market Purchase | 7,135 | $22.38 | $159,684.00 | < 1% 8.27M to 8.28M | < 1% |
| 18-Nov-21 3:41 PM View: | Applied Molecular Transport... (AMTI) | 16-Nov-21 | Market Purchase | 4,000 | $22.57 | $90,298.40 | < 1% 8.26M to 8.27M | (< 1%) |
| 09-Feb-21 6:39 PM View: | Lucira Health, Inc. (LHDX) | 05-Feb-21 | Conversion | 9,694,760 | $1.29 | $12,503,100.00 | 100% 0 to 9.69M | |
| 09-Feb-21 6:39 PM View: | Lucira Health, Inc. (LHDX) | 05-Feb-21 | Purchase | 3,461,760 | $17.00 | $58,850,000.00 | 36% 9.69M to 13.16M | |
| 15-Jun-20 6:55 PM View: | Quince Therapeutics, Inc. (QNCX) | 12-Jun-20 | Market Purchase | 2,440 | $44.06 | $107,506.00 | < 1% 2.86M to 2.86M | (33%) |
| 15-Jun-20 6:55 PM View: | Quince Therapeutics, Inc. (QNCX) | 11-Jun-20 | Market Purchase | 6,600 | $44.32 | $292,512.00 | < 1% 2.85M to 2.86M | (33%) |
| 11-Jun-20 5:55 PM View: | Applied Molecular Transport... (AMTI) | 09-Jun-20 | Conversion | 5,544,240 | -- | -- | 100% 0 to 5.54M | |
| 11-Jun-20 5:55 PM View: | Applied Molecular Transport... (AMTI) | 09-Jun-20 | Purchase | 2,720,000 | $14.00 | $38,080,000.00 | 49% 5.54M to 8.26M | |
| 22-May-20 6:03 PM View: | Quince Therapeutics, Inc. (QNCX) | 22-May-20 | Market Purchase | 2,085 | $55.90 | $116,552.00 | < 1% 2.85M to 2.85M | (47%) |
| 22-May-20 6:03 PM View: | Quince Therapeutics, Inc. (QNCX) | 21-May-20 | Market Purchase | 520 | $55.80 | $29,016.00 | < 1% 2.85M to 2.85M | (47%) |
| 22-May-20 6:03 PM View: | Quince Therapeutics, Inc. (QNCX) | 20-May-20 | Market Purchase | 6,085 | $57.95 | $352,605.00 | < 1% 2.84M to 2.85M | (49%) |
| 31-Jan-20 1:40 PM View: | Quince Therapeutics, Inc. (QNCX) | 29-Jan-20 | Disposition (other) | 4,338 | $54.30 | $235,553.00 | (< 1%) 2.85M to 2.84M | 46% |
| 21-Aug-19 4:54 PM View: | Quince Therapeutics, Inc. (QNCX) | 21-Aug-19 | Market Purchase | 420 | $24.87 | $10,444.80 | < 1% 8.5M to 8.5M | 19% |
| 21-Aug-19 4:54 PM View: | Quince Therapeutics, Inc. (QNCX) | 21-Aug-19 | Market Purchase | 1,635 | $24.87 | $40,660.00 | < 1% 8.5M to 8.5M | 19% |
| 21-Aug-19 4:54 PM View: | Quince Therapeutics, Inc. (QNCX) | 20-Aug-19 | Market Purchase | 600 | $25.69 | $15,414.00 | < 1% 8.49M to 8.49M | 15% |
| 21-Aug-19 4:54 PM View: | Quince Therapeutics, Inc. (QNCX) | 20-Aug-19 | Market Purchase | 2,310 | $25.69 | $59,343.90 | < 1% 8.49M to 8.5M | 15% |
| 19-Aug-19 5:10 PM View: | Quince Therapeutics, Inc. (QNCX) | 19-Aug-19 | Market Purchase | 2,100 | $26.50 | $55,639.90 | < 1% 2.83M to 2.83M | 11% |
| 19-Aug-19 5:10 PM View: | Quince Therapeutics, Inc. (QNCX) | 16-Aug-19 | Market Purchase | 700 | $26.37 | $18,460.00 | < 1% 2.83M to 2.83M | 12% |
| 14-Jun-19 12:48 PM View: | Quince Therapeutics, Inc. (QNCX) | 10-May-19 | Purchase | 4,350 | $26.41 | $114,884.00 | < 1% 8.47M to 8.47M | |
| 14-Jun-19 12:48 PM View: | Quince Therapeutics, Inc. (QNCX) | 10-May-19 | Purchase | 4,250 | $27.57 | $117,173.00 | < 1% 8.47M to 8.48M |